Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martee Hensley
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
201 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- University of California San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Olive View-University of California Los Angeles Medical Center
Sylmar, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Colorado Cancer Research Program Ccop
Denver, Colorado, United States
- Exempla Saint Joseph Hospital
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Rocky Mountain Gynecologic Oncology Pc
Englewood, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Saint Anthony Hospital
Lakewood, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- Saint Mary Corwin Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Scl Health Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2009
- Primary completion
- 30 Sept 2015
- Completion
- 30 Sept 2015
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 107
- Registry id
- NCT01012297
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.